In head and neck squamous cell carcinoma (HNSCC), use of SW-682 to block YAP/TAZ-TEAD binding led to an antitumor response in FAT1-mutant HNSCC xenograft models (85). The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.